[go: up one dir, main page]

AP2001002245A0 - Regulation of anesthesia. - Google Patents

Regulation of anesthesia.

Info

Publication number
AP2001002245A0
AP2001002245A0 APAP/P/2001/002245A AP2001002245A AP2001002245A0 AP 2001002245 A0 AP2001002245 A0 AP 2001002245A0 AP 2001002245 A AP2001002245 A AP 2001002245A AP 2001002245 A0 AP2001002245 A0 AP 2001002245A0
Authority
AP
ARIPO
Prior art keywords
subject
anesthesia
regulation
delta
inducing peptide
Prior art date
Application number
APAP/P/2001/002245A
Other languages
English (en)
Inventor
Christopher John Douglas Pomfret
Michael Alkire
Richard Haier
Jim Fallon
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of AP2001002245A0 publication Critical patent/AP2001002245A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/2001/002245A 1999-02-05 2000-02-01 Regulation of anesthesia. AP2001002245A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
US12032699P 1999-02-17 1999-02-17
US15566199P 1999-09-24 1999-09-24
PCT/GB2000/000281 WO2000045832A2 (fr) 1999-02-05 2000-02-01 Regulation d'anesthesie

Publications (1)

Publication Number Publication Date
AP2001002245A0 true AP2001002245A0 (en) 2001-09-30

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002245A AP2001002245A0 (en) 1999-02-05 2000-02-01 Regulation of anesthesia.

Country Status (15)

Country Link
EP (1) EP1148887A2 (fr)
JP (1) JP2002536337A (fr)
KR (1) KR20010101992A (fr)
CN (1) CN1346278A (fr)
AP (1) AP2001002245A0 (fr)
AU (1) AU2445900A (fr)
BR (1) BR0008046A (fr)
CA (1) CA2360124A1 (fr)
ID (1) ID30518A (fr)
IL (1) IL144572A0 (fr)
MX (1) MXPA01007949A (fr)
NO (1) NO20013795L (fr)
OA (1) OA11758A (fr)
TR (1) TR200102265T2 (fr)
WO (1) WO2000045832A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (fr) * 2001-07-13 2003-01-15 The Procter & Gamble Company Composition alimentaire ayant des propriétés relaxantes pour les mammifères
WO2009033814A2 (fr) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (zh) * 2018-02-28 2020-10-16 复旦大学附属中山医院 乙醛脱氢酶2基因型在麻醉剂量计算中的应用
CN112535727A (zh) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 一种具有睡眠改善作用的短肽凝胶及其制备方法
CN112908454B (zh) * 2021-02-26 2023-08-29 西安交通大学口腔医院 一种智能保管麻醉剂的方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.
CA1188989A (fr) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide pour le traitement des symptomes du sevrage
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
RU2104717C1 (ru) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Способ анестезии при операциях у больных с синдромом лериша

Also Published As

Publication number Publication date
WO2000045832A2 (fr) 2000-08-10
MXPA01007949A (es) 2003-06-04
NO20013795D0 (no) 2001-08-02
NO20013795L (no) 2001-08-02
BR0008046A (pt) 2001-11-06
JP2002536337A (ja) 2002-10-29
CN1346278A (zh) 2002-04-24
IL144572A0 (en) 2002-05-23
AU2445900A (en) 2000-08-25
ID30518A (id) 2001-12-13
CA2360124A1 (fr) 2000-08-10
KR20010101992A (ko) 2001-11-15
TR200102265T2 (tr) 2001-12-21
WO2000045832A3 (fr) 2000-11-30
EP1148887A2 (fr) 2001-10-31
OA11758A (en) 2005-07-19

Similar Documents

Publication Publication Date Title
WO2001085664A3 (fr) Composes et procedes utilises pour reguler la croissance bacterienne et la pathogenie
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
ATE394082T1 (de) Vorrichtung zur verbindung von wirbeln der wirbelsäule
WO2003002717A3 (fr) Activite biologique de ak155
BG103886A (en) Regulation of the expression of quinolate phospho- ribosyltransferase
UA84432C2 (ru) Очищенные пептиды и соединения, которые их содержат
MX9706969A (es) 3-(1,2,3,6-tetrahidropiridin-4-il)-1h-indoles y 3-(piperidin-4-il)-1h-indoles sustituidos en la posicion 5: agonistas del 5-ht1f novedosos.
PT1671949E (pt) Piridinilaminas substituídas
EP2093569A3 (fr) Compositions et procédés pour la quantification de glycoprotéines sériques
ZA948926B (en) Non-peptide tachykinin recptor antagonists
DE60237917D1 (de) Gfats als modifikatoren des p53-wegs und verwendungsverfahren
ATE466582T1 (de) 16-phenoxy-lipoxin analoge zur medizinischen verwendung
IL175770A0 (en) Novel use of peptide compounds for treating central neuropathic pain
AU2002228912A1 (en) Short peptides from the "a-region" of protein kinases which selectively modulate protein kinase activity
WO2004032851A3 (fr) Criblage et procedes therapeutiques lies a la neurogenese
AP2001002245A0 (en) Regulation of anesthesia.
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
ATE311802T1 (de) Gargerät
PL346246A1 (en) Modulating multiple lineage kinase proteins
MY112148A (en) Suspension concentrate compositions of arylpyrrole insecticidal and acarricidal agents
WO2002066045A3 (fr) Procedes de modulation de reponse immune par modulation de l'interaction entre ctla4 et pp2a
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
DE69724062D1 (de) Benzothiophenderivate, Zwischenprodukte, Verfahren, Zubereitungen und Methoden
GB0115382D0 (en) Mutant
GB0216299D0 (en) Wick arrangement for an anaesthetic vaporizer